Individualized Prediction for Risk of Recurrence in Stage I/<scp>II</scp> Melanoma Patients With Negative Sentinel Lymph Node
We developed a Risk Score to predict long-term risk of recurrence for early-stage melanoma patients. A Gompertz survival model fit to the Risk Score allows for individualized prediction of time-dependent recurrence risk.
Authors
- Richard Essner (ORCID: https://orcid.org/0000-0002-2146-8417)
- Kristel Lourdault (ORCID: https://orcid.org/0000-0003-2875-5918)
- Douglas Hanes (ORCID: https://orcid.org/0000-0001-7131-3096)
- Shu‐Ching Chang (ORCID: https://orcid.org/0000-0002-6534-0124)
- Gary L. Grunkemeier
- Shih‐Ting Chiu
- Stacey L. Stern
Institutions
- Oregon Health & Science University (US)
- Providence College (US)
- Saint John's Health Center (US)
- St. Joseph Health System (US)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2024-11-29
- DOI
- https://doi.org/10.1002/cam4.70441
- Primary Topic
- Cutaneous Melanoma Detection and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Society of Thoracic Surgeons